Bicycle Therapeutics plc

NasdaqGS:BCYC Stock Report

Market Cap: US$289.7m

Bicycle Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:BCYC Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
06 Apr 26SellUS$11,877Michael SkynnerIndividual2,404US$5.05
06 Apr 26SellUS$8,736Michael HannayIndividual1,772US$5.05
06 Apr 26SellUS$4,438Travis ThompsonIndividual901US$5.05
06 Apr 26SellUS$37,964Kevin LeeIndividual7,683US$5.05
05 Jan 26SellUS$38,206Alethia YoungIndividual5,745US$6.80
05 Jan 26SellUS$141,199Kevin LeeIndividual21,314US$6.80
05 Jan 26SellUS$34,491Michael HannayIndividual5,194US$6.80
05 Jan 26SellUS$44,127Alistair MilnesIndividual6,660US$6.80
05 Jan 26SellUS$41,804Michael SkynnerIndividual6,311US$6.80
05 Jan 26SellUS$16,147Travis ThompsonIndividual2,432US$6.80
03 Oct 25SellUS$17,860Alistair MilnesIndividual2,125US$8.41
03 Oct 25SellUS$2,723Travis ThompsonIndividual324US$8.41
03 Oct 25SellUS$15,147Michael SkynnerIndividual1,802US$8.41
03 Oct 25SellUS$46,182Kevin LeeIndividual5,494US$8.41
03 Oct 25SellUS$6,076Michael HannayIndividual723US$8.41
02 Oct 25SellUS$1,823Alethia YoungIndividual217US$8.40

Insider Trading Volume

Insider Buying: BCYC insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of BCYC?
Owner TypeNumber of SharesOwnership Percentage
State or Government61,1530.0876%
Individual Insiders1,256,6701.8%
General Public10,738,01715.4%
Institutions27,432,08439.3%
Hedge Funds30,323,30143.4%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 78.33% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
43.4%
Baker Bros. Advisors LP
30,323,301US$125.8m0%0.67%
4.97%
Forbion Capital Partners B.V.
3,468,430US$14.4m0%2.18%
4.87%
Armistice Capital LLC
3,398,000US$14.1m5.01%0.38%
4.74%
Long Focus Capital Management LLC
3,310,687US$13.7m103%0.54%
2.82%
Acadian Asset Management LLC
1,968,025US$8.2m17.8%0.01%
2.24%
Artal Group S.A.
1,560,882US$6.5m-22.5%0.12%
2.19%
GSK Equity Investments, Limited
1,529,561US$6.3m0%0.62%
1.68%
Principal Global Investors, LLC
1,174,625US$4.9m2.3%no data
1.47%
T. Rowe Price Group, Inc.
1,028,243US$4.3m-12.3%no data
1.4%
Renaissance Technologies LLC
979,300US$4.1m72.8%0.01%
0.89%
Morgan Stanley
618,327US$2.6m32.9%no data
0.88%
Schroder Investment Management Limited
615,833US$2.6m5.31%no data
0.86%
Kevin Lee
598,811US$2.5m1.43%no data
0.68%
Diadema Partners LP
476,424US$2.0m0%0.9%
0.66%
Birchview Capital, LP
463,599US$1.9m0.19%0.96%
0.61%
Silvercrest Asset Management Group LLC
428,684US$1.8m-10.1%0.01%
0.54%
Marshall Wace LLP
377,335US$1.6m873%no data
0.54%
Citadel Advisors LLC
377,085US$1.6m39%no data
0.49%
Medical Strategy GmbH
343,416US$1.4m0%0.09%
0.44%
Qube Research & Technologies Ltd
308,617US$1.3m637%no data
0.41%
Millennium Management LLC
283,986US$1.2m-13.1%no data
0.4%
BlackRock, Inc.
278,992US$1.2m-16.2%no data
0.39%
Moore Capital Management, LP
275,000US$1.1m0%0.04%
0.38%
Bessemer Investment Management LLC
265,973US$1.1m25.3%no data
0.33%
Rangeley Capital, LLC
232,260US$963.9k76%0.81%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/16 21:27
End of Day Share Price 2026/06/16 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Bicycle Therapeutics plc is covered by 21 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Arlinda LeeCanaccord Genuity
Li Wang WatsekCantor Fitzgerald & Co.
Alethia YoungCantor Fitzgerald & Co.